News & Perspective

Oct 25, 2019

Oct 25, 2019

News Scan for Oct 25, 2019

First US flu deaths in kids
Oral HPV in young women
Promising rapid TB test
Animal virus surveillance program ends
Trial of new anthrax vaccine

Aug 22, 2016

Aug 22, 2016
DA Henderson

Infectious disease field loses 'commander-in-chief' D.A. Henderson

Besides leading smallpox eradication, Henderson is also known for his role in shaping public health education and for instilling passion for solving infectious disease problems.

Jul 10, 2014

Jul 10, 2014

News Scan for Jul 10, 2014

Questions on anthrax scare
Ebola in Liberian health workers
Office for climate and health

Jun 06, 2014

Jun 06, 2014

News Scan for Jun 06, 2014

More West Africa Ebola
Lab-linked Salmonella outbreak
Public health at World Cup
Neglected zoonotic diseases

Jan 22, 2013

Jan 22, 2013

Select-agent safety reports find little public health risk

(CIDRAP News) – The risks in working with potentially dangerous pathogens in US labs are low to the scientists involved as well as to the general public, according to two recent reports on safety incidents.

Dec 11, 2012

Dec 11, 2012

HHS offers some forecasts on medical countermeasures

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

Oct 18, 2012

Oct 18, 2012

HHS seeks comments on risks of H5N1 research

(CIDRAP News) – Federal health officials are inviting the public to weigh in on whether research on H5N1 avian influenza viruses, including strains modified in the lab to make them more transmissible, is risky enough to require new safety regulations and precautions.

Pages

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»